highly significantP<0.001
Cla at into group A (<20'!.) and group B (> 20% of cels staming postively for the p53 protein). Group B patents had a highly significant risk of proson (P<0.001, log-rank test).
Cla at into group A (<20'!.) and group B (> 20% of cels staming postively for the p53 protein). Group B patents had a highly significant risk of proson (P<0.001, log-rank test).